Mortality analysis in hip fracture patients: implications for design of future outcome trials. implications for design of future outcome trials

Patients with hip fractures are usually frail and elderly with a 30-day mortality in excess of 10% in European series. Perioperative morbidity is often multifactorial in nature, and unimodal interventions will not necessarily decrease mortality. The purpose of this prospective study was to analyse causes of mortality, and thereby the potential and limitations to decrease mortality after hip fracture surgery.